A weight loss drug has reduced the risk of type 2 diabetes by 80 per cent compared to placebo.

The drug, which increases the amount of appetite-supressing hormones produced by the gut, was tested on overweight people with ‘prediabetes’. This is also known as ‘borderline diabetes,’ and is characterised by slightly increased blood sugar levels. The condition often leads to type 2 diabetes when untreated.

Read more at Imperial College London.